$ENDV#OTCQB Endonovo Therapeutics, Inc. (ENDV: OTCQB) | Endonovo Therapeutics Announces Significant Results From Study Showing 70% Reduction of Morphine Equivalent Dose and 2 Day Reduction of Length of Stay at […]
$ENDV#OTCQB Endonovo Therapeutics, Inc. (ENDV: OTCQB) | Endonovo Therapeutics Announces Effectiveness of Registration of Equity Credit Line and Ceasing Variable Convertible Note Financing
Copyright 2020 – OTC M […]
$ENDV#OTCQB Endonovo Therapeutics, Inc. (ENDV: OTCQB) | Endonovo Therapeutics Announces International Expansion with Distribution Agreement for SofPulse® in Taiwan, Republic of China
Copyright 2020 – OTC Markets Group Inc.
$ENDV#OTCQB Endonovo Therapeutics, Inc. (ENDV: OTCQB) | Endonovo Therapeutics Enters into $10 million Equity Line Agreement with Cavalry Fund
Copyright 2019 – OTC Markets Group Inc.
$ENDV#OTCQB Endonovo Therapeutics, Inc. (ENDV: OTCQB) | Endonovo Therapeutics Announces Eight Additional Hospitals Approved Use of SofPulse® at Their Facilities
Copyright 2019 – OTC Markets Group Inc.
$ENDV#OTCQB Endonovo Therapeutics, Inc. (ENDV: OTCQB) | Endonovo Therapeutics Announces Eight Additional Hospitals Approved Use of SofPulse® at Their Facilities
Copyright 2019 – OTC Markets Group Inc.
